Dr Reddys Laboratories (RDY) Equity Income (2011 - 2023)
Dr Reddys Laboratories' Equity Income was $84,502 in the quarter ended Jun 30, 2026, up 261.6% from $23,369 a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Equity Income (2011 - 2023) Analysis & Trends
On a trailing twelve-month basis, Dr Reddys Laboratories' Equity Income was $17.36 billion through Jun 30, 2026, down 13.2% year-over-year; for the year ended Mar 31, 2026, it came in at $1 million, down 100.0% from the prior year.
- Equity Income shows a five-year compound annual growth rate of -32.2% (years ended Mar 2021 to Mar 2026).
- In earlier years, Equity Income was $76.58 billion in the year ended Mar 31, 2025, $2 million in the year ended Mar 31, 2024, -$5 million in the year ended Mar 31, 2023 and $9 million in the year ended Mar 31, 2022 (+28.6%).
- Quarterly Equity Income has moved between -$2 million (the quarter ended Sep 30, 2021) and $20 billion (the quarter ended Mar 31, 2025) over five years.
- Compared with a year earlier, Equity Income was higher in three of the last six quarters, with growth averaging 28.4%.
- Per Business Quant data, RDY's Equity Income in the three quarters before the quarter ended Jun 30, 2026 was $1.95 billion (quarter ended Mar 31, 2026), $15.41 billion (quarter ended Dec 31, 2025) and $722,279 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | - |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Dr Reddys Laboratories | 10.90 Bn | 10.27 Bn | 396.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Dec 31, 2021 | -2.00 Mn |
| Sep 30, 2021 | -2.00 Mn |
| Jun 30, 2021 | -3.00 Mn |
| Mar 31, 2021 | -2.00 Mn |
| Jun 30, 2020 | -2.00 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | -2.00 Mn |
| Sep 30, 2019 | -2.00 Mn |
| Jun 30, 2019 | -2.00 Mn |
| Mar 31, 2019 | -2.00 Mn |
| Dec 31, 2018 | -2.00 Mn |
| Sep 30, 2018 | -1.00 Mn |
| Mar 31, 2018 | -1.00 Mn |
| Dec 31, 2017 | -1.00 Mn |
| Sep 30, 2017 | -1.00 Mn |
API Access
Dr Reddys Laboratories Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();